| Remission in depression: definition and initial treatment approaches JA Israel Journal of psychopharmacology 20 (3_suppl), 5-10, 2006 | 89 | 2006 |
| The impact of residual symptoms in major depression JA Israel Pharmaceuticals 3 (8), 2426-2440, 2010 | 85 | 2010 |
| Transcranial magnetic stimulation in young persons: a review of known cases G Walter, JM Tormos, JA Israel, A Pascual-Leone Journal of child and adolescent Psychopharmacology 11 (1), 69-75, 2001 | 76 | 2001 |
| Elevated cholesterol levels associated with nonresponse to fluoxetine treatment in major depressive disorder SB Sonawalla, GI Papakostas, TJ Petersen, AS Yeung, MM Smith, ... Psychosomatics 43 (4), 310-316, 2002 | 67 | 2002 |
| Amphetamine usage and genital self‐mutilation JA Israel, K Lee Addiction 97 (9), 1215-1218, 2002 | 36 | 2002 |
| Combining stimulants and monoamine oxidase inhibitors: a reexamination of the literature and a report of a new treatment combination JA Israel The Primary Care Companion for CNS Disorders 17 (6), 26135, 2015 | 11 | 2015 |
| Elevated cholesterol levels in major depressive disorder associated with non-response to fluoxetine treatment S Sonawalla, GI Papakostas, T Petersen, AS Yeung, M Smith, ... Psychosomatics 43 (4), 310-316, 2002 | 9 | 2002 |
| Polypharmacy to optimize depression outcomes: rational polypharmacy may extend beyond evidence-based combinations JA Israel Psychiatric Times 25 (9), 17-17, 2008 | 2 | 2008 |
| Achieving remission in depression: is the bar set too high or too low?(vol 20, pg 5, 2006) JE Alpert, C DeBattista, M Fava, JA Israel, TJ Petersen, LL Carpenter JOURNAL OF PSYCHOPHARMACOLOGY 20 (6), 869-869, 2006 | | 2006 |
| Combining Stimulants and Monoamine Oxidase Inhibitors JA Israel | | |
